Sonika Asija
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sonika Asija has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Yogesh Deswal
Department of Chemistry, Central University of Haryana
9 shared publicationsNaresh Kumar
Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar, India
6 shared publications- Deepak Kumar
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, India
5 shared publications Pinki Barwa
Department of Chemistry, Guru Jambheshwar University of Science & Technology
5 shared publicationsAshwani Kumar
Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, India
4 shared publications- Jai Devi
Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar, India
4 shared publications
Latest Publications
- 17 September 2026
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 52 (11) , 7721-7744
Assessment of biological potency of 2-(cyclohexyloxy)acetohydrazide based diorganotin(IV) complexes: synthesis, spectral characterization, crystallographic and computational studies
- 17 September 2026
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 52 (11) , 7721-7744
Assessment of biological potency of 2-(cyclohexyloxy)acetohydrazide based diorganotin(IV) complexes: synthesis, spectral characterization, crystallographic and computational studies
- 28 July 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1378
Multifunctional furyl/thienyl 1,2,3-triazoles: crystal structure, DFT insights and antimicrobial potential
- 28 July 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1378
Multifunctional furyl/thienyl 1,2,3-triazoles: crystal structure, DFT insights and antimicrobial potential
- 10 June 2026
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 52 (9) , 1-35
Antimalarial, antioxidant, and antimicrobial evaluation of pyrazole-hydrazone metal(II) complexes via docking and ADMET studies
- 10 June 2026
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 52 (9) , 1-35
Antimalarial, antioxidant, and antimicrobial evaluation of pyrazole-hydrazone metal(II) complexes via docking and ADMET studies
- 28 April 2026
- Published by Springer Nature in Chemical Papers
- Vol. 80 (8) , 1-24
Exploring hydrazone-derived organotin(IV) complexes as multifunctional antimicrobial and anticancer agents: a review
- 28 April 2026
- Published by Springer Nature in Chemical Papers
- Vol. 80 (8) , 1-24
Exploring hydrazone-derived organotin(IV) complexes as multifunctional antimicrobial and anticancer agents: a review
- 13 November 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1353
Synthesis, antimicrobial activity and DFT study of piperazine-phthalimide clubbed 1,4-disubstituted 1,2,3-triazoles
- 13 November 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1353
Synthesis, antimicrobial activity and DFT study of piperazine-phthalimide clubbed 1,4-disubstituted 1,2,3-triazoles
- 7 January 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (2)
Diorganotin(IV) Complexes Containing Hydrazone Ligands as Prospective Bioactive Agents: Synthesis, Crystal Structure, Spectroscopic Analysis, Anticancer, and Antimicrobial Activity
The exploration of diorganotin(IV) compounds as potential inhibitors of cancer cell growth is gaining attention. Here, we have emphasized the potential of diorganotin derivatives as promising candidates for anticancer therapy. Thus, a series of Schiff base core tin(IV) complexes, including dimethyl, diethyl, dibutyl, and diphenyl derivatives, were synthesized and examined utilizing mass spectrometry, FT‐IR, NMR, and single crystal XRD. The acquired spectroscopy results disclosed that hydrazone ligands connected to tin atom in a tridentate fashion via phenolic O, imine N, and enolic O donor atoms and formed a pentacoordinated environment, which was further validated by X‐ray crystallographic diffraction study of compound 9 . Single crystal X‐ray examination of compound 9 demonstrated that the Sn atom is arranged in a distorted five‐coordinated square pyramidal geometry. The antimicrobial potential of all prepared compounds was examined against four bacterial and two fungal strains, and complexes 7 , 11 , and 15 having MIC values between 0.0043 and 0.0050 μmol/mL exhibit better effectiveness against Escherichia coli and Candida albicans . Further, synthesized compounds were examined for in vitro anticancer efficacy against MCF‐7 and A549 cell lines and demonstrated substantial activity with standard Doxorubicin. Compounds 3 and 5 , being the most active, were subsequently evaluated against normal cell line HEK 293T.
- 7 January 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (2)
Diorganotin(IV) Complexes Containing Hydrazone Ligands as Prospective Bioactive Agents: Synthesis, Crystal Structure, Spectroscopic Analysis, Anticancer, and Antimicrobial Activity
The exploration of diorganotin(IV) compounds as potential inhibitors of cancer cell growth is gaining attention. Here, we have emphasized the potential of diorganotin derivatives as promising candidates for anticancer therapy. Thus, a series of Schiff base core tin(IV) complexes, including dimethyl, diethyl, dibutyl, and diphenyl derivatives, were synthesized and examined utilizing mass spectrometry, FT‐IR, NMR, and single crystal XRD. The acquired spectroscopy results disclosed that hydrazone ligands connected to tin atom in a tridentate fashion via phenolic O, imine N, and enolic O donor atoms and formed a pentacoordinated environment, which was further validated by X‐ray crystallographic diffraction study of compound 9 . Single crystal X‐ray examination of compound 9 demonstrated that the Sn atom is arranged in a distorted five‐coordinated square pyramidal geometry. The antimicrobial potential of all prepared compounds was examined against four bacterial and two fungal strains, and complexes 7 , 11 , and 15 having MIC values between 0.0043 and 0.0050 μmol/mL exhibit better effectiveness against Escherichia coli and Candida albicans . Further, synthesized compounds were examined for in vitro anticancer efficacy against MCF‐7 and A549 cell lines and demonstrated substantial activity with standard Doxorubicin. Compounds 3 and 5 , being the most active, were subsequently evaluated against normal cell line HEK 293T.
- 19 August 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 38 (12)
Exploring the Microbial Inhibition Ability of Newly Synthesized Diorganotin(IV) Complexes of Hydrazone Ligands: Structural Elucidation, Crystal Structure, and DFT Studies
In our work, we have successfully synthesized twelve diorganotin(IV) complexes (4–15) from different hydrazone ligands and diorganotin(IV) dichlorides. The complexes have a general formula [R2SnL1–3], where R = Et, Me, Bu, and Ph groups. The hydrazone ligands (1–3) were synthesized through a condensation reaction involving 3‐ethoxysalicylaldehyde with different benzhydrazide derivatives. All the synthesized hydrazone ligands and their complexes underwent screening by employing numerous spectroscopic and physicochemical techniques, such as molar conductance measurements, mass spectrometry, (1H, 119Sn, and 13C) NMR, SEM‐EDAX, and FT‐IR. Spectroscopic analysis revealed that the hydrazone ligands were attached to tin atoms in a tridentate fashion via ONO donor atoms, suggesting a pentacoordinated geometry for the complexes. Furthermore, the X‐ray crystallography analysis for Complex 6 revealed the distorted square pyramidal geometry around the tin atom. Moreover, a DFT study was also carried out for Ligand 3 and its complexes (12–15) by employing B3LYP/LanL2DZ theory level (Gaussian 9 software package) to obtain the optimized geometry and global reactivity descriptors, structural behavior, and their efficacy against different microbes. To assess the biological efficacy of synthesized compounds, an in vitro antimicrobial assay was conducted against different fungal (Aspergillus niger and Candida albicans) and bacterial (Staphylococcus aureus, Bacillus subtilis, Escherichia coli, and Pseudomonas aeruginosa) strains. The results of the antimicrobial assay demonstrated that Complexes 7, 11, and 15 depicted better results against E. coli strain and C. albicans strain, implying that the higher lipophilic character of these complexes facilitates their easy passage through the cell membrane of microbes. Furthermore, an ADMET study was carried out to evaluate the toxicity score of synthesized compounds.
- 19 August 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 38 (12)
Exploring the Microbial Inhibition Ability of Newly Synthesized Diorganotin(IV) Complexes of Hydrazone Ligands: Structural Elucidation, Crystal Structure, and DFT Studies
In our work, we have successfully synthesized twelve diorganotin(IV) complexes (4–15) from different hydrazone ligands and diorganotin(IV) dichlorides. The complexes have a general formula [R2SnL1–3], where R = Et, Me, Bu, and Ph groups. The hydrazone ligands (1–3) were synthesized through a condensation reaction involving 3‐ethoxysalicylaldehyde with different benzhydrazide derivatives. All the synthesized hydrazone ligands and their complexes underwent screening by employing numerous spectroscopic and physicochemical techniques, such as molar conductance measurements, mass spectrometry, (1H, 119Sn, and 13C) NMR, SEM‐EDAX, and FT‐IR. Spectroscopic analysis revealed that the hydrazone ligands were attached to tin atoms in a tridentate fashion via ONO donor atoms, suggesting a pentacoordinated geometry for the complexes. Furthermore, the X‐ray crystallography analysis for Complex 6 revealed the distorted square pyramidal geometry around the tin atom. Moreover, a DFT study was also carried out for Ligand 3 and its complexes (12–15) by employing B3LYP/LanL2DZ theory level (Gaussian 9 software package) to obtain the optimized geometry and global reactivity descriptors, structural behavior, and their efficacy against different microbes. To assess the biological efficacy of synthesized compounds, an in vitro antimicrobial assay was conducted against different fungal (Aspergillus niger and Candida albicans) and bacterial (Staphylococcus aureus, Bacillus subtilis, Escherichia coli, and Pseudomonas aeruginosa) strains. The results of the antimicrobial assay demonstrated that Complexes 7, 11, and 15 depicted better results against E. coli strain and C. albicans strain, implying that the higher lipophilic character of these complexes facilitates their easy passage through the cell membrane of microbes. Furthermore, an ADMET study was carried out to evaluate the toxicity score of synthesized compounds.
- 1 December 2023
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 57 (9) , 1372-1383
Synthesis, Characterization, and In Vitro Antimicrobial and Antioxidant Study of the Pentacoordinated Organotin(IV) Complexes Based on Acid Hydrazide Schiff Base Ligands
- 1 December 2023
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 57 (9) , 1372-1383
Synthesis, Characterization, and In Vitro Antimicrobial and Antioxidant Study of the Pentacoordinated Organotin(IV) Complexes Based on Acid Hydrazide Schiff Base Ligands